Immunohistochemical properties of ocular adenomas, adenocarcinomas and medulloepitheliomas

Veterinary Ophthalmology

Volumn 9, Issue 6, 2006, Pages 387-394

  Klosterman, E ^a   Colitz, C M H ^a   Chandler, H L ^a   Kusewitt, D F ^a   Saville, W J A ^a   Dubielzig, R R ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adenocarcinoma; Adenoma; Canine; Ciliary body epithelium; Immunohistochemistry; Medulloepithelioma; Telomerase; Telomerase reverse transcriptase (TERT)

Indexed keywords

ANTIBODY; DIAGNOSTIC AGENT; TUMOR MARKER;

ADENOCARCINOMA; ADENOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EVALUATION; EYE TUMOR; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; NEUROECTODERM TUMOR; PREDICTION AND FORECASTING;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTIBODIES; DOG DISEASES; DOGS; EYE NEOPLASMS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEUROECTODERMAL TUMORS, PRIMITIVE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750470083     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2006.00478.x     Document Type: Article

References (52)

1. Hendrix DVH, Bochsler PN, Saladina B et al. Malignant teratoid medulloepithelioma in a llama. Veterinary Pathology 2000; 37: 680-683.
2. Kivela T, Tarkkanen A. Recurrent medulloepithelioma of the ciliary body. Ophthalmology 1988; 95: 1565-1575.
3. al-Torbak A, Abboud EB, al-Sharif A et al. Medulloepithelioma of the ciliary body. Indian Journal of Ophthalmology 2002; 50: 138-140.
4. Yanoff M, Fine BS. Ocular melanocytic tumors. In: Ocular Pathology, 5th edn. Mosby, Philadelphia, 2002; 639-699.
5. Bras ID, Metzler AG, Kusewitt DF et al. Immunohistochemical characterization of a malignant intraocular teratoid medulloepithelioma in a cockatiel. Veterinary Ophthalmology 2005; 8: 59-65.
6. Wilcock B, Williams MM. Malignant intraocular medulloepithelioma in a dog. Journal of the American Animal Hospital Association 1980; 16: 617-619.
7. Eagle RC, Font RL, Swercsek TW. Malignant medulloepithelioma of the optic nerve in a horse. Veterinary Pathology 1978; 15: 488-494.
8. LaBowit SE, Katz HR, Hirschbein MJ et al. Topical 0.3% ciprofloxacin vs. topical 0.3% ofloxacin in early treatment of pseudomonas aeruginosa keratitis in a rabbit model. Annals of Ophthalmology 2001; 33: 48-52.
9. Lahav M, Albert DM, Kircher CH et al. Malignant teratoid medulloepithelioma in a dog. Veterinary Pathology 1976; 13: 11-16.
10. Lahav M, Albert DM. Medulloepithelioma of the ciliary body in the goldfish (Carassius auratus). Veterinary Pathology 1978; 15: 208-212.
11. Schmidt RE, Becker LL, McElroy JM. Malignant teratoid medulloepithelioma in two cockatiels. Journal of the American Veterinary Medical Association 1976; 189: 1105-1106.
12. Ueda Y, Senba H, Nishimura T et al. Ocular medulloepithelioma in a thoroughbred. Equine Veterinary Journal 1993; 25: 558-561.
13. Langloss JM, Zimmerman LE, Krehbiel JD. Malignant intraocular teratoid medulloepithelioma in three dogs. Veterinary Pathology 1976; 13: 343-352.
14. Jelinek F, Mirejovsky P, Voskova D et al. Medulloepithelioma in a cat. Cesko-slovenska Patologie 1996; 32: 75-77.
15. Dubielzig RR, Steinberg H, Garvin H et al. Iridociliary epithelial tumors in 100 dogs and 17 cats: a morphological study. Veterinary Ophthalmology 1998; 1: 223-231.
16. Biller BJ, Kitchell BE, Cadile CD. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. American Journal of Veterinary Research 1998; 59: 1526-1529.
17. Funakoshi Y, Nakayama H, Uetsuka K et al. Cellular proliferation and telomerase activity in canine mammary gland tumors. Veterinary Pathology 2000; 37: 177-183.
18. Ickowski KA, Pantazis CG, McGregor DH et al. Telomerase reverse transcriptase subunit immunoreactivity. A marker for high-grade prostate carcinoma. Cancer 2002; 95: 2487-2493.
19. Schneider-Stock R, Boltze C, Jager V et al. Elevated telomerase activity, c-MYC, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumors. Journal of Pathology 2003; 199: 517-525.
20. Wang Z, Ramin SA, Tsai C et al. Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens. Urologic Oncology 2002; 7: 199-205.
21. Colitz CMH, Malarkey DE, Dykstra MJ et al. Histologic and immunohistochemical characterization of lens capsular plaques in dogs with cataracts. American Journal of Veterinary Research 2000; 61: 139-143.
22. Laver NM, Hidayat AA, Croxatto JO. Pleomorphic adenomas of the ciliary epithelium. Immunohistochemical and ultrastructural features of 12 cases. Ophthalmology 1999; 106: 103.
23. Yanoff M, Fine BS. Retinoblastoma and psuedoglioma. In: Ocular Pathology. (eds Yanoff M, Fine BS) Mosby, Philadelphia, 2002; 701-726.
24. Apple DJ, Rabb MF. Retinoblastoma, leukokoria, and phakomatoses. In: Ocular Pathology. (eds Apple DJ, Rabb MF) Mosby, St Louis, 1998; 480-526.
25. Broughton WL, Zimmerman LE. A clinicopathologic study of 56 cases of intraocular medulloepitheliomas. American Journal of Ophthalmology 1978; 85: 407-418.
26. Green WR, Iliff WJ, Trotter RR. Malignant teratoid medulloepithelioma of the optic nerve. Archives of Ophthalmology 1974; 91: 451-454.
27. Khoddami M, Becker LE. Immunohistochemistry of medulloepithelioma and neural tube. Pediatric Pathology and Laboratory Medicine 1997; 17: 913-925.
28. Kim NW, Piatyszek MA, Prowse PR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2014.
29. Rhyu MS. Telomeres, telomerase and immortality. Journal of the National Cancer Institute 1995; 87: 884-894.
30. Blasco MA, Gasser SM, Lingner J. Telomeres and telomerase. Genes and Development 1999; 13: 2353-2359.
31. Feng J, Funk WD, Whang S-S et al. The RNA component of human telomerase. Science 1995; 269: 1236-1241.
32. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Archiv 2000; 437: 1-16.
33. Weinrich SL, Pruzan R, Ma L et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genetics 1997; 17: 498-502.
34. Nakayama J-I, Tahara H, Tahara E et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genetics 1998; 18: 65-68.
35. Beattie TL, Zhou W, Robinson MO et al. Reconstitution of human telomerase activity in vitro. Current Biology 1998; 8: 177-180.
36. Mattson MP, Klapper W. Emerging roles for telomerase in neuronal development and apoptosis. Journal of Neuroscience Research 2001; 63: 1-9.
37. Fu W, Killen M, Pandita TK et al. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. Journal of Molecular Neuroscience 2000; 14: 3-15.
38. Mattson MP, Fu W, Zhang P. Telomerase, DNA damage and apoptosis. In: Telomerase, Aging and Disease. (eds Mattson MP, Pandita TK) Elsevier Science, Amsterdam, 2001; 131-150.
39. Zagorski Z. Histopathological studies of human lenses. Lens and Eye Toxicology Research 1991; 8: 311-318.
40. Kyo S, Masutomi K, Maida Y et al. Significance of immunological detection of human telomerase reverse transcriptase. American Journal of Pathology 2003; 163: 859-867.
41. Tahara H, Yasui W, Tahara E et al. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 1999; 18: 1561-1567.
42. Poremba C, Scheel C, Hero B et al. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. Journal of Clinical Oncology 2000; 18: 2582-2592.
43. Poremba C, Heine B, Diallo R et al. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Journal of Pathology 2002; 198: 181-189.
44. Cabuy E, de Ridder L. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Archiv 2001; 439: 176-184.
45. Braunstein I, Cohen-Barak O, Shachaf C et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Cancer Research 2001; 61: 5529-5536.
46. Espinosa de los Monteros A, Fernandez A, Millan MY et al. Coordinate expression of cytokeratin 7 and 20 in feline and canine carcinomas. Veterinary Pathology 1999; 36: 179-190.
47. Ramaekers F, Huysmans A, Schaart G et al. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Experimental Cell Research 1987; 170: 235-249.
48. Ramaekers F, van Niekerk C, Poels L et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. American Journal of Pathology 1999; 136: 641-655.
49. Moll R, Lowe A, Laufer J et al. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. American Journal of Pathology 1992; 140: 427-447.
50. Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. Journal of Cell Biology 1990; 111: 567-580.
51. Terasaki H, Nagasaka T, Arai M et al. Adenocarcinoma of the nonpigmented ciliary epithelium: report of two cases with immunohistochemical findings. Graefes Archive for Clinical and Experimental Ophthalmology 2001; 239: 876-881.
52. Schulman FY, Lipscomb TP, Atkin TJ. Canine cutaneous clear cell adnexal carcinoma: histopathology, immunohistochemistry, and biologic behavior of 26 cases. Journal of the Veterinary Diagnostic Investigation 2005; 17: 403-411.